HAS2 and neoplasm: These findings suggest that fibrotic TME and HSC-derived CAFs in liver metastases promote tumor growth in steatotic liver, and that HSC-derived HAS2 and HA-mediated CD44 activation could play a role in developing a metastatic TME in steatotic liver.